Weiss Multi-Strategy Advisers’s Immune Design Corp. IMDZ Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-27,500	Closed	-$95K	–	689
2018 Q3	$95K	Hold	27,500	–	–	﹤0.01%	497
2018 Q2	$125K	Sell	27,500 -52,500	-66%	-$209K	﹤0.01%	526
2018 Q1	$264K	Sell	80,000 -89,034	-53%	-$315K	0.01%	493
2017 Q4	$659K	Buy	+169,034	New	+$921K	0.02%	477
2017 Q2	–	Sell	-50,000	Closed	-$340K	–	740
2017 Q1	$340K	Sell	50,000 -50,000	-50%	-$289K	0.01%	498
2016 Q4	$550K	Buy	+100,000	New	+$706K	0.03%	316

Other funds holding IMDZ

Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCPEM

Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Weiss Multi-Strategy Advisers's IMDZ Position: Q4 2018 in Review

Weiss Multi-Strategy Advisers sold out of Immune Design Corp. (IMDZ) in Q4 2018, closing a stake of 27,500 shares — an estimated $95K sold.

Weiss Multi-Strategy Advisers first reported a position in IMDZ in Q4 2016 and held it in 6 quarters. The position peaked at $659K in Q4 2017. 64 funds tracked by Wall St. Rank hold IMDZ as of Q4 2018.

Weiss Multi-Strategy Advisers reported no remaining Immune Design Corp. position as of Q4 2018 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 27,500 Immune Design Corp. shares in Q4 2018, an estimated $95K.
Weiss Multi-Strategy Advisers first reported a position in Immune Design Corp. in Q4 2016 and held it in 6 quarters.
Weiss Multi-Strategy Advisers's Immune Design Corp. position peaked at $659K in Q4 2017.
64 funds tracked by Wall St. Rank held Immune Design Corp. as of Q4 2018.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2018, filed 14 Feb 2019.